43 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
Jurisdictions that Prevent Inspections 90 PART III Item 10. Directors, Executive Officers and Corporate Governance 91 Item 11. Executive Compensation 91 … electronically with the SEC. A copy of our Corporate Governance Guidelines, Code of Business Conduct and Ethics and the charters of the (i) Audit Committee, (ii
8-K
EX-99.1
4zbp 8f4g3tjk49cwj9
22 Feb 24
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:15am
8-K
EX-99.1
idx le9c0rc
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
eaqrdy fj
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
ARS
eem3c i7lp61qs
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
yrvrvc4q5bk8i1
18 Apr 23
Preliminary proxy
7:59am
8-K
EX-99.1
2b7n9xc j2p9le69
4 Aug 22
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:15am
8-K
p5dg533fdbdm tg041
2 Aug 22
C4 Therapeutics Appoints Experienced Clinical Development Leaders Laura Bessen, M.D. and Donna Grogan, M.D. to Board of Directors
8:33am
8-K
EX-99.1
c9zd9z8uv agx1
5 May 22
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
8:06am